Friday 6 November 2026 Export CSTL’s income statement to Excel — free account

Castle Biosciences, Inc.

Castle Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $344.2 million, up 3.66% from fiscal 2024.

Revenue: +23.9%
EPS: −550.0%
Free cash flow: +56.8%
Total debt: −59.9%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

32.65 1.55 −4.53%

Follow CSTL

Alert me

Market cap: $1.0B
P/E: 0.0×
Fwd P/E: −29.8×
Dividend yield: —
F-score: 3/9
Altman Z: 6.70
Beneish M: −3.49
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	3	3	4
ROE Full definition →		(5.21%)	(2.85%)	(4.20%)	(4.87%)
ROA Full definition →		(4.35%)	(2.45%)	(3.51%)	(4.03%)
ROIC Full definition →		(14.72%)	(9.90%)	(9.40%)	(3.63%)
Return on Tangible Assets Full definition →		(6.20%)	(3.37%)	(4.99%)	(5.74%)
Average Days of Receivables Full definition →		46.00	45.38	49.39	50.43
Free Cash Flow per Share Full definition →		0.98	0.15	(0.01)	0.13
Free Cash Flow Full definition →		28.37	4.56	(0.45)	3.99
Capital Expenditures Full definition →		(35.98)	(43.69)	(43.09)	(35.75)
Other line items
Cash ROIC Full definition →		3.63%	0.62%	(0.06%)	0.83%
Accounts Receivable Turnover Full definition →		7.28	6.89	7.10	7.43
Accounts Payable Turnover Full definition →		5.55	6.39	7.11	6.80
Inventory Turnover Full definition →		7.73	8.69	8.58	9.09
Average Days of Payables Full definition →		96.15	73.01	43.43	55.83
Days of Inventory on Hand Full definition →		52.69	50.79	47.53	43.82
Tax Rate Full definition →		(0.18)	(0.27)	0.01	0.02
Research and Development Expense of Revenue Full definition →		15.06%	15.79%	15.52%	15.46%
Selling, General and Administrative Expense of Revenue Full definition →		66.62%	69.31%	68.20%	66.70%
Share Based Compensation of Revenue Full definition →		13.33%	13.09%	12.56%	11.67%
Interest Coverage Full definition →		(497.79)	(163.99)	(85.62)	(51.16)
Operating CF/Net income Full definition →		(2.66)	(3.76)	(2.20)	(1.73)
Depreciation/Fixed assets Full definition →		0.38	0.12	0.13	0.13
Capex/Depreciation Full definition →		(0.98)	(3.74)	(3.28)	(2.54)
Revenue per Share Full definition →		11.88	11.37	11.75	12.31
Operating CF per Share Full definition →		2.22	1.61	1.40	1.30
Capex per Share Full definition →		(1.24)	(1.46)	(1.42)	(1.17)
Capex to Sales Full definition →		0.10	0.13	0.12	0.09

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly